IX Acquisition Seeks Fourth Extension to Avoid Liquidation, Sponsor Contribution Declines

TL;DR

**IXQWF is on life support, needing another extension to avoid liquidation, and the sponsor's reduced contribution signals a tougher road ahead; redeem now or risk it all on a last-ditch deal.**

AI Summary

IX Acquisition Corp. (IXQWF) is seeking shareholder approval for a Fourth Extension Amendment to its memorandum and articles of association, allowing its board of directors to extend the deadline for a business combination from October 12, 2025, to October 12, 2026. This is the fourth such extension sought since its IPO on October 12, 2021. The company's sponsor, IX Acquisition Sponsor LLC, has agreed to contribute the lesser of $40,000 or $0.03 per outstanding Public Share monthly into the Trust Account if the extension is approved, a decrease from the $50,000 or $0.03 per share contributed during the Third Extension. As of September 19, 2025, the Trust Account held approximately $19.8 million, equating to a redemption price of approximately $12.31 per Public Share, which is higher than the Class A Ordinary Shares' closing price of $12.01 on September 21, 2025. Without this extension, the company would be forced to liquidate on October 12, 2025, and Public Shareholders would receive their pro rata portion of the Trust Account, while warrants would expire worthless.

Why It Matters

This filing is critical for IX Acquisition Corp. investors as it directly impacts the company's ability to complete a business combination and avoid liquidation. The proposed Fourth Extension provides a lifeline, but the reduced monthly contribution from IX Acquisition Sponsor LLC, from $50,000 to $40,000 (or $0.03 per share), signals potential waning sponsor commitment or increased difficulty in securing a target. For public shareholders, the redemption value of approximately $12.31 per share, currently above the market price of $12.01, offers a clear exit option, influencing their decision to redeem or hold for a potential future deal. The broader SPAC market watches these extensions closely as they reflect the challenges in finding suitable merger targets and maintaining investor confidence.

Risk Assessment

Risk Level: high — The risk level is high because IX Acquisition Corp. faces imminent liquidation on October 12, 2025, if the Fourth Extension Amendment Proposal is not approved. This is the fourth extension sought, indicating significant difficulty in securing a business combination since its October 12, 2021 IPO. The sponsor's monthly contribution for the extension has decreased from $50,000 (or $0.03 per share) during the Third Extension to $40,000 (or $0.03 per share) for the Fourth Extension, suggesting potential financial strain or reduced confidence.

Analyst Insight

Investors should carefully consider redeeming their Public Shares for approximately $12.31 per share by October 6, 2025, given the market price of $12.01 and the high risk of liquidation. If the extension is approved, the reduced sponsor contribution and continued delays suggest a challenging path to a successful business combination, making redemption a potentially safer option.

Key Numbers

• $19.8M — Funds in Trust Account (As of September 19, 2025, available for redemption)
• $12.31 — Redemption price per Public Share (Pro rata portion of Trust Account funds as of September 19, 2025)
• $12.01 — Closing price of Class A Ordinary Shares (On Over-the-Counter Markets (OTCM) on September 21, 2025)
• $40,000 — Sponsor's monthly contribution (Lesser of this amount or $0.03 per Public Share for Fourth Extension)
• $50,000 — Previous sponsor's monthly contribution (For the Third Extension, indicating a decrease in commitment)
• October 12, 2025 — Current business combination deadline (Without the Fourth Extension, company faces liquidation)
• October 12, 2026 — Proposed new business combination deadline (If Fourth Extension Amendment is approved)
• October 8, 2025 — Date of Extraordinary General Meeting (Shareholders to vote on extension proposals)
• October 6, 2025 — Deadline to tender Public Shares for redemption (Two business days prior to the Meeting)
• 2/3 — Required vote for Fourth Extension Amendment (Special resolution of Ordinary Shares, voting as a single class)

Key Players & Entities

• IX Acquisition Corp. (company) — Registrant seeking extension
• IX Acquisition Sponsor LLC (company) — Sponsor contributing funds to Trust Account
• Noah Aptekar (person) — Chief Executive Officer
• CBIZ CPAs P.C. (company) — Independent registered public accounting firm
• Loeb & Loeb LLP (company) — Location of the extraordinary general meeting
• Giovanni Caruso (person) — Contact for meeting attendance at Loeb & Loeb LLP
• Cantor Fitzgerald & Co. (company) — Owner of Private Placement Warrants
• Odeon Capital Group, LLC (company) — Owner of Private Placement Warrants
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for filings

FAQ

Risk Factors

• Liquidation Risk Due to Unconsummated Business Combination [high — financial]: IX Acquisition Corp. faces liquidation on October 12, 2025, if shareholders do not approve the Fourth Extension Amendment. This would result in public shareholders receiving their pro rata portion of the Trust Account, currently at $19.8 million, and warrants expiring worthless.
• Decreased Sponsor Support for Extension [medium — financial]: The sponsor's monthly contribution to the Trust Account for the Fourth Extension is reduced to the lesser of $40,000 or $0.03 per Public Share, down from $50,000 or $0.03 per share during the Third Extension. This indicates a potentially lower commitment from the sponsor to facilitate further extensions.
• Share Price Below Trust Account Value [medium — market]: As of September 21, 2025, the closing price of Class A Ordinary Shares was $12.01, which is below the redemption price of approximately $12.31 per Public Share from the Trust Account. This suggests a lack of market confidence or potential arbitrage opportunities for shareholders.
• Repeated Need for Business Combination Extensions [medium — operational]: This is the fourth extension sought by IX Acquisition Corp. since its IPO on October 12, 2021. The repeated need for extensions suggests potential difficulties in identifying and closing a suitable business combination within the initial timeframe.

Industry Context

IX Acquisition Corp. operates within the Special Purpose Acquisition Company (SPAC) industry. The SPAC market has seen increased activity and subsequent scrutiny, with many companies facing challenges in identifying and completing target acquisitions within their mandated timelines. This often leads to extensions and, in some cases, liquidation, impacting investor returns.

Regulatory Implications

The company is subject to SEC regulations governing proxy solicitations and SPAC operations. The repeated extensions and potential liquidation highlight the regulatory framework designed to protect public shareholders by ensuring timely completion of business combinations or return of capital.

What Investors Should Do

1. Review the Fourth Extension Amendment Proposal carefully.
2. Consider tendering Public Shares for redemption by October 6, 2025.
3. Monitor the company's progress in identifying a business combination target.

Key Dates

• 2025-10-08: Extraordinary General Meeting — Shareholders will vote on the Fourth Extension Amendment Proposal, Auditor Ratification Proposal, and Adjournment Proposal.
• 2025-10-06: Deadline to tender Public Shares for redemption — Shareholders must submit their shares for redemption if they wish to exercise this right prior to the meeting.
• 2025-10-12: Current business combination deadline — Without the Fourth Extension, the company will be forced to liquidate.
• 2026-10-12: Proposed new business combination deadline — If the Fourth Extension Amendment is approved, the company will have until this date to complete a business combination.
• 2021-10-12: Initial Public Offering (IPO) consummation — Marks the beginning of the initial 18-month period to complete a business combination.

Glossary

Business Combination

A merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. (This is the primary objective of IX Acquisition Corp., and the failure to complete one leads to liquidation.)

Trust Account

A U.S.-based trust account holding a portion of the IPO proceeds and private placement funds, available for redemptions and business combinations. (Contains the funds that public shareholders are entitled to upon redemption or liquidation.)

Public Shares

Class A ordinary shares of the Company included as part of the units sold in the IPO. (These are the shares held by public shareholders who have redemption rights.)

Sponsor

IX Acquisition Sponsor LLC, a Delaware limited liability company that is the sponsor of IX Acquisition Corp. (The sponsor makes contributions to the Trust Account to facilitate extensions and has specific rights and obligations.)

Fourth Extension Amendment

An amendment to the company's memorandum and articles of association to extend the deadline for a business combination. (The core proposal shareholders are being asked to approve to avoid liquidation.)

Redemption

The act of a public shareholder electing to have their Public Shares redeemed for cash from the Trust Account. (A key right for public shareholders, especially if the business combination is not completed or if they wish to exit.)

Year-Over-Year Comparison

This filing represents the fourth request for an extension, indicating a continued struggle to finalize a business combination since the IPO in October 2021. The previous filing likely detailed the Third Extension Amendment, which allowed for extensions up to October 12, 2025, with a sponsor contribution of $50,000 per month. This current filing shows a reduced sponsor contribution for the Fourth Extension, suggesting a potentially weaker commitment or financial position of the sponsor. The core risk of liquidation remains, but the timeline is now extended to October 12, 2026, contingent on shareholder approval.

Key Financial Figures

• $160,000 — company (the " Sponsor ") will deposit $160,000 into the Trust Account (as defined belo
• $50,000 — in an amount equal to the lesser of (x) $50,000 or (y) $0.015 for each of the Company's
• $0.015 — ual to the lesser of (x) $50,000 or (y) $0.015 for each of the Company's Public Shares
• $0.0001 — dinary shares of the Company, par value $0.0001 per share (the " Class A Ordinary Share
• $19.8 million — s in the Trust Account of approximately $19.8 million as of such date, the pro rata portion o
• $12.31 — nt for the Redemption was approximately $12.31 per Public Share (before taking into ac
• $12.01 — s (" OTCM ") on September 21, 2025, was $12.01. The Company cannot assure shareholders
• $40,000 — e Company, as a loan, the lesser of (x) $40,000 or (y) $0.03 for each Public Share that
• $0.03 — loan, the lesser of (x) $40,000 or (y) $0.03 for each Public Share that remains outs
• $100,000 — e Company (less taxes payable and up to $100,000 of interest to pay dissolution expenses

Filing Documents

• tm2525690-2_def14a.htm (DEF 14A) — 433KB
• 0001104659-25-092566.txt ( ) — 435KB

From the Filing

DEF 14A 1 tm2525690-2_def14a.htm DEF 14A tm2525690-2_def14a - none - 4.2656345s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a-12 IX ACQUISITION CORP. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS IX ACQUISITION CORP. 53 DAVIES STREET LONDON, W1K 5JH UNITED KINGDOM LETTER TO SHAREHOLDERS Dear IX Acquisition Corp. Shareholder: You are cordially invited to attend an extraordinary general meeting in lieu of an annual general meeting of the shareholders (the " Meeting ") of IX Acquisition Corp., a Cayman Islands exempted company (the " Company "), which will be held on October 8, 2025, at 10:00 a.m. Eastern Time, at the offices of Loeb & Loeb LLP, located at 345 Park Avenue, 21st Floor, New York, New York 10154, or at such other time, on such other date and at such other place to which the Meeting may be adjourned. You will be permitted to attend the Meeting in person at the offices of Loeb & Loeb LLP if you reserve your attendance at least two business days in advance of the Meeting by contacting Loeb & Loeb LLP, c/o Giovanni Caruso, 345 Park Avenue, 21st Floor, New York, New York, 10154. Even if you plan to attend the Meeting, it is strongly recommended you complete and return your proxy card before the Meeting date, to ensure that your shares will be represented at the Meeting if you are unable to attend. You will not be required to attend the Meeting in person in order to vote. You will be able to vote your shares online by visiting www.cstproxyvote.com. The accompanying proxy statement (the " Proxy Statement ") is dated September 22, 2025, and is first being mailed to shareholders of the Company on or about September 23, 2025. The accompanying Proxy Statement describes the business the Company will conduct at the Meeting and provides information about the Company that you should consider when you vote your shares. The Meeting will be held for the purpose of considering and voting on the following proposals (the " Proposals "): 1. Proposal One—Fourth Extension Amendment Proposal — To approve, by way of special resolution, an amendment to the Company's amended and restated memorandum and articles of association, as amended and currently in effect (the " Memorandum and Articles of Association "), in the form set forth in Annex A to the accompanying Proxy Statement (the " Fourth Extension Amendment " and such proposal, the " Fourth Extension Amendment Proposal "), to give the Company's board of directors (the " Board ") the right to extend the date by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a " Business Combination ") from October 12, 2025 on a monthly basis up to twelve (12) times until October 12, 2026 (or such earlier date as determined by the Board), which we refer to as the " Fourth Extension ", and such later date, the " Fourth Extended Date "; 2. Proposal Two—Auditor Ratification Proposal — To ratify the selection by the audit committee of the Board of CBIZ CPAs P.C. (" CBIZ ") to serve as our independent registered public accounting firm for the year ending December 31, 2025 (the " Auditor Ratification Proposal "); and 3. Proposal Three—Adjournment Proposal — To adjourn the Meeting to a later date or dates or indefinitely, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any of the foregoing Proposals (the " Adjournment Proposal "). For the avoidance of doubt, if put forth at the Meeting, the Adjournment Proposal will be the first and only proposal voted on and the Fourth Extension Amendment Proposal and the Auditor Ratification Proposal will not be submitted to the shareholders for a vote. Each of the Proposals are more fully described in the accompanying Proxy Statement; please take the time to read carefully each of the Proposals before you vote. The Company's final prospectus filed in connection with the Company's initial public offering that was consummated on October 12, 2021 (the " IPO "), which was filed with the U.S. Securities and Exchange

View Full Filing

View this DEF 14A filing on SEC EDGAR